[{"Assets_0_Q3_USD":30669804.0,"CommonStockSharesOutstanding_0_Q3_shares":10032687.0,"NetCashProvidedByUsedInOperatingActivities_3_Q3_USD":-15853679.0,"NetIncomeLoss_1_Q3_USD":-4926097.0,"NetIncomeLoss_3_Q3_USD":-12084936.0,"StockholdersEquity_0_Q3_USD":15235022.0,"RevenueFromContractWithCustomerExcludingAssessedTax_1_Q3_USD":2828704.0,"RevenueFromContractWithCustomerExcludingAssessedTax_3_Q3_USD":7987198.0,"Ticker":"BNGO","CIK":"1411690","name":"BIONANO GENOMICS, INC","OfficialName":"Bionano Genomics Inc. Common Stock","form":"10-Q","period":"20180930","fy":"2018.0","fp":"Q3","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"573433639.0","Country":"United States","Sector":"Capital Goods","Industry":"Biotechnology: Laboratory Analytical Instruments","Market":"NASDAQ","SP500":"nan","filed":"20181107"}]